Reva Schneider

495 citations
17 papers · 353 indexed · h-index 7
Topics
Cancer Immunotherapy and Biomarkers (3 papers)Lymphoma Diagnosis and Treatment (3 papers)interferon and immune responses (2 papers)

In The Last Decade

Reva Schneider

15 papers receiving 348 citations

Peers

Reva Schneider
Comparison fields: 5 of 48
  • Surgery 135
  • Oncology 119
  • Physiology 117
  • Immunology 86
  • Molecular Biology 57
Replace Katharina M. Scheurlen with:
Katharina M. Scheurlen United States
Richard A. Lutes United States
Jiaze Hong China
Anne V. Spedding United Kingdom
Sefa Tüzün Türkiye
Kazuo To Japan
Emily Koeck United States
Tına Mistry United Kingdom
N. Ansorge Germany
Dorothée Thuillier France
Reva Schneider relative to Katharina M. Scheurlen United States Katharina M. Scheurlen's profile →
Citations per field
00.5×10×15×22×
Katharina M. Scheurlen · 1×
Citations per year

Countries citing papers authored by Reva Schneider

Since Specialization
Citations

This map shows the geographic impact of Reva Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reva Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reva Schneider more than expected).

Fields of papers citing papers by Reva Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reva Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reva Schneider. The network helps show where Reva Schneider may publish in the future.

Co-authorship network of co-authors of Reva Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Reva Schneider. A scholar is included among the top collaborators of Reva Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reva Schneider. Reva Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 10
2 0
3 6
4 2
5 0
6 4
7 3
8 63
9 1
10 20
11 48
12 4
13 1
14 1
15 31
16 158
17 1

About Reva Schneider

Reva Schneider is a scholar working on Cancer Research, Oncology and Immunology, having authored 17 papers that have together received 353 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Physiology (117 citations), Oncology (119 citations) and Immunology (86 citations). Reva Schneider has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Elizabeth Odstrcil, Jack L. Porter, Joseph A. Kuhn, Juan Gabriel Martı́nez, John S. Fordtran, Carol A. Santa Ana, John R. Asplin, John Pippen, Cynthia R. Osborne and Sandip Pravin Patel. Their work appears in journals such as Journal of Clinical Oncology, Blood and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026